Cargando…

The Combination of Low Skeletal Muscle Mass and High Tumor Interleukin-6 Associates with Decreased Survival in Clear Cell Renal Cell Carcinoma

Clear cell renal carcinoma (ccRCC) is frequently associated with cachexia which is itself associated with decreased survival and quality of life. We examined relationships among body phenotype, tumor gene expression, and survival. Demographic, clinical, computed tomography (CT) scans and tumor RNASe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kays, Joshua K., Koniaris, Leonidas G., Cooper, Caleb A., Pili, Roberto, Jiang, Guanglong, Liu, Yunlong, Zimmers, Teresa A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352265/ https://www.ncbi.nlm.nih.gov/pubmed/32560494 http://dx.doi.org/10.3390/cancers12061605

Ejemplares similares

Modelling survival
por: Zimmers, Teresa A, et al.
Publicado: (2019)

STAT3 Activation in Skeletal Muscle Links Muscle Wasting and the Acute Phase Response in Cancer Cachexia
por: Bonetto, Andrea, et al.
Publicado: (2011)

Profiling of Adipose and Skeletal Muscle in Human Pancreatic Cancer Cachexia Reveals Distinct Gene Profiles with Convergent Pathways
por: Narasimhan, Ashok, et al.
Publicado: (2021)

Pathological Responses of Cardiac Mitochondria to Burn Trauma
por: Wang, Meijing, et al.
Publicado: (2020)

Three cachexia phenotypes and the impact of fat‐only loss on survival in FOLFIRINOX therapy for pancreatic cancer
por: Kays, Joshua K., et al.
Publicado: (2018)

The MEK-Inhibitor Selumetinib Attenuates Tumor Growth and Reduces IL-6 Expression but Does Not Protect against Muscle Wasting in Lewis Lung Cancer Cachexia
por: Au, Ernie D., et al.
Publicado: (2017)

Identification of Potential Serum Protein Biomarkers and Pathways for Pancreatic Cancer Cachexia Using an Aptamer-Based Discovery Platform
por: Narasimhan, Ashok, et al.
Publicado: (2020)

Sarcopenia is a Significant Predictor of Mortality After Abdominal Aortic Aneurysm Repair
por: Kays, Joshua K., et al.
Publicado: (2018)

Ethical Implications of Modifying Lethal Injection Protocols
por: Koniaris, Leonidas G, et al.
Publicado: (2008)

Do Plastic Surgery Programs with Integrated Residencies or Subspecialty Fellowships Have Increased Academic Productivity?
por: Duquette, Stephen P., et al.
Publicado: (2016)

Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin
por: Zhong, Xiaoling, et al.
Publicado: (2022)

Lethal Injection for Execution: Chemical Asphyxiation?
por: Zimmers, Teresa A, et al.
Publicado: (2007)

The impact of inflammation and acute phase activation in cancer cachexia
por: Robinson, Tyler P., et al.
Publicado: (2023)

Differential Bone Loss in Mouse Models of Colon Cancer Cachexia
por: Bonetto, Andrea, et al.
Publicado: (2017)

The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy
por: Zhong, Xiaoling, et al.
Publicado: (2019)

Determining the Drivers of Academic Success in Surgery: An Analysis of 3,850 Faculty
por: Valsangkar, Nakul P., et al.
Publicado: (2015)

Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia
por: Rupert, Joseph E., et al.
Publicado: (2021)

Decreased Expression of ACADSB Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Liu, Xianhui, et al.
Publicado: (2022)

Inflammation, organomegaly, and muscle wasting despite hyperphagia in a mouse model of burn cachexia
por: Pedroso, Felipe E., et al.
Publicado: (2012)

High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma
por: Pan, Deng, et al.
Publicado: (2015)

Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma
por: Zhang, Jun, et al.
Publicado: (2022)

ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma
por: Green, Yangsook Song, et al.
Publicado: (2022)

Editorial: Improving post-surgical outcomes for patients with primary gastrointestinal stromal tumors
por: Koniaris, Leonidas G., et al.
Publicado: (2023)

Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma
por: Gao, Yuan, et al.
Publicado: (2020)

Metastatic clear cell renal cell carcinoma to the forearm without identifiable primary renal mass
por: Walton, John, et al.
Publicado: (2019)

Retracted: Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Specialized care improves outcomes for patients with cirrhosis who require general surgical operations
por: Kays, Joshua K., et al.
Publicado: (2019)

HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma
por: Ramakrishnan, Swathi, et al.
Publicado: (2016)

Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma
por: Su, Hengchuan, et al.
Publicado: (2016)

Decreased expression of JMJD3 predicts poor prognosis of patients with clear cell renal cell carcinoma
por: Wang, Jiajun, et al.
Publicado: (2017)

Decreased CDKL2 Expression in Clear Cell Renal Cell Carcinoma Predicts Worse Overall Survival
por: Chen, Zhan, et al.
Publicado: (2022)

Decreased Expression of GLYATL1 Predicts Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma
por: Deng, Limin, et al.
Publicado: (2023)

Pathway Signature and Cellular Differentiation in Clear Cell Renal Cell Carcinoma
por: Tun, Han W., et al.
Publicado: (2010)

Clear cell renal cell carcinoma located in sinus renalis confused with renal pelvis mass in image
por: Wu, Pengjie, et al.
Publicado: (2015)

Decreased β-Cell Function Is Associated with Reduced Skeletal Muscle Mass in Japanese Subjects without Diabetes
por: Sakai, Satoshi, et al.
Publicado: (2016)

Loss of early B cell protein λ5 decreases bone mass and accelerates skeletal aging
por: Khass, Mohamed, et al.
Publicado: (2022)

Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma
por: Wu, Song, et al.
Publicado: (2011)

Decreased Expression of SETD2 Predicts Unfavorable Prognosis in Patients With Nonmetastatic Clear-Cell Renal Cell Carcinoma
por: Liu, Weisi, et al.
Publicado: (2015)

Overexpression of Parkin in clear cell renal cell carcinoma decreases tumor aggressiveness by regulating CKS2 levels
por: Esser, Laura Kristin, et al.
Publicado: (2022)

Sex and the clinical value of body mass index in patients with clear cell renal cell carcinoma
por: Ohno, Y, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ekbpm6avnmo1s4a3jm3f0k8fio